Article info
PDFClinical
Short report
Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services
- Correspondence to Dr Michaela Joanne Day, Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI), National Infection Service, Public Health England National Infection Service, London NW9 5EQ, UK; michaela.day{at}phe.gov.uk
Citation
Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services
Publication history
- Received November 30, 2020
- Accepted May 9, 2021
- First published June 4, 2021.
Online issue publication
April 12, 2022
Article Versions
- Previous version (4 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.